Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 4, 2009, Pages 821-823

  Sauermann, Robert ^a   Schwameis, Richard ^a   Fille, Manfred ^b   Camuz ligios, Maria Luciana ^a   Zeitlinger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

CO2; CSF; pH; PK PD simulation; Time kill curves

Indexed keywords

FOSFOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BROTH DILUTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; FOSFOMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MODELS, THEORETICAL; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 70349470705     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp261     Document Type: Article

References (9)

1. Zhanel GG, Karlowsky JA, Davidson RJ et al. Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli. Antimicrob Agents Chemother 1992; 36: 1136-9.
2. Sauermann R, Schwameis R, Fille M et al. Antimicrobial activity of cefepime and rifampicin in cerebrospinal fluid in vitro. J Antimicrob Chemother 2008; 62: 1057-60.
3. Pfausler B, Spiss H, Dittrich P et al. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother 2004; 53: 848-52.
4. Gobernado M. Fosfomycin. Rev Esp Quimioter 2003; 16: 15-40.
5. Cunniffe JG, Whitby-Strevens S, Wilcox MH. Effect of pH changes in cerebrospinal fluid specimens on bacterial survival and antigen test results. J Clin Pathol 1996; 49: 249-53.
6. Nau R, Zysk G, Reinert RR et al. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis. J Antimicrob Chemother 1995; 36: 997-1004.
7. Ribes S, Taberner F, Domenech A et al. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2006; 57: 931-6.
8. Grif K, Dierich MP, Pfaller K et al. In vitro activity of fosfomycin in combination with various antistaphylococcal substances. J Antimicrob Chemother 2001; 48: 209-17.
9. Dette GA, Knothe H, Schonenbach B et al. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues. J Antimicrob Chemother 1983; 11: 517-24.